- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Menieres Disease.
Displaying page 1 of 1.
EudraCT Number: 2006-005913-37 | Sponsor Protocol Number: no sponsor | Start Date*: 2009-03-09 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: Intratympanic gentamicin therapy for M Meniere: a comparison of two regimes | |||||||||||||
Medical condition: Patients suffering of Menieres disease for at least 6 moths without sufficient relief of symptoms through medicinal therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004496-71 | Sponsor Protocol Number: 104-201508 | Start Date*: 2016-03-01 | |||||||||||
Sponsor Name:Otonomy Inc. | |||||||||||||
Full Title: A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 3 efficacy and safety study of OTO-104 given as a single intratympanic injection in subjects with unilateral Meniere’... | |||||||||||||
Medical condition: Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) BE (Completed) DE (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002375-22 | Sponsor Protocol Number: 38RC15.173 | Start Date*: 2015-07-27 | |||||||||||
Sponsor Name:University Hospital Grenoble | |||||||||||||
Full Title: Study the diffusion kinetics of gadolinium at the perilymph of the inner ear structures to patients Meniere's disease | |||||||||||||
Medical condition: Patients Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001337-86 | Sponsor Protocol Number: 104-201403 | Start Date*: 2014-07-11 | |||||||||||
Sponsor Name:Otonomy Inc. | |||||||||||||
Full Title: A 6-month, prospective, randomized, multicenter, placebo-controlled safety study of OTO-104 given at 3-month intervals by intratympanic injection in subjects with unilateral Meniere's disease, foll... | |||||||||||||
Medical condition: Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000766-29 | Sponsor Protocol Number: 104-201610 | Start Date*: 2016-07-29 | |||||||||||
Sponsor Name:Otonomy Inc. | |||||||||||||
Full Title: A 6-MONTH, MULTICENTER, PHASE 3, OPEN-LABEL EXTENSION SAFETY STUDY OF OTO-104 GIVEN AT 3-MONTH INTERVALS BY INTRATYMPANIC INJECTION IN SUBJECTS WITH UNILATERAL MENIERE’S DISEASE | |||||||||||||
Medical condition: Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) BE (Completed) DE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000752-32 | Sponsor Protocol Number: 04T-617 | Start Date*: 2006-01-23 | |||||||||||
Sponsor Name:Klinikum Grosshadern | |||||||||||||
Full Title: Medical treatment of Menière’s disease with betahistine: a placebo-controlled, dose-finding study | |||||||||||||
Medical condition: Ménière’s disease is a disorder of the inner ear membranous labyrinth characterized by paroxysmal vertiginous attacks, fluctuating sensorineural hearing loss, aural fullness, and tinnitus .The unde... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001464-35 | Sponsor Protocol Number: 104-201811 | Start Date*: 2018-11-06 | |||||||||||
Sponsor Name:Otonomy, Inc. | |||||||||||||
Full Title: A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 3 efficacy and safety study of OTO-104 given as a single intratympanic injection in subjects with unilateral Meniere’... | |||||||||||||
Medical condition: Meniere's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.